diazoxide has been researched along with pargyline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Khattri, HN; Wahi, PL | 1 |
| Vidt, DG | 1 |
| Selchau, M | 1 |
| Dhasmana, KM; Fokker, WA; Spilker, BA | 1 |
| Hellman, B; Lernmark, A; Sehlin, J; Täljedal, IB | 1 |
| Frohman, LA | 1 |
| ROWE, WS | 1 |
2 review(s) available for diazoxide and pargyline
| Article | Year |
|---|---|
Choice of antihypertensive drugs for the treatment of hypertension, including hypertensive emergencies.
Topics: Antihypertensive Agents; Bethanechol Compounds; Clonidine; Diazoxide; Diuretics; Emergencies; Ferricyanides; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Muscle, Smooth; Pargyline; Propranolol; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Vasodilator Agents | 1974 |
[Angiotics. 48. I. Hypertensive agents. II. Hypotensive agents. 3. Vasodilator agents. IV. Agents for the treatment of lipid metabolism disorders].
Topics: Acetylcholine; Adenosine Triphosphate; Amines; Angiotensin II; Anticholesteremic Agents; Antihypertensive Agents; Diazoxide; Ergot Alkaloids; Humans; Hyperlipidemias; Kallikreins; Lipid Mobilization; Methyldopa; Nicotinic Acids; Parasympatholytics; Pargyline; Phenethylamines; Phytotherapy; Plants, Medicinal; Propylamines; Protoveratrines; Purines; Rauwolfia; Sympatholytics; Sympathomimetics; Tissue Extracts; Vasodilator Agents | 1970 |
6 other study(ies) available for diazoxide and pargyline
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Drug treatment of hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Debrisoquin; Diazoxide; Diuretics; Female; Humans; Hypertension; Male; Methyldopa; Pargyline; Secologanin Tryptamine Alkaloids | 1976 |
Peripheral cardiovascular effects, in the pithed rat, of compounds used in the treatment of hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Cordotomy; Diazoxide; Electric Stimulation; Ergotamine; Guanethidine; Hydrochlorothiazide; Iproniazid; Male; Mecamylamine; Methyldopa; Pargyline; Phenobarbital; Rats; Reserpine; Sympathetic Nervous System; Thiocyanates; Trimethaphan | 1972 |
Transport and storage of 5-hydroxytryptamine in pancreatic -cells.
Topics: Animals; Biological Transport; Carbon Isotopes; Chromatography, Gel; Diazoxide; Glucose; Glyburide; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred Strains; Obesity; Osmolar Concentration; Pargyline; Protein Binding; Reserpine; Serotonin | 1972 |
Stimulation of insulin secretion in rats by pargyline and mebanazine.
Topics: Animals; Blood Glucose; Diazoxide; Epinephrine; Female; Glucose; Hydrazines; Insulin; Insulin Secretion; Monoamine Oxidase Inhibitors; Pancreas; Pargyline; Rats; Stimulation, Chemical | 1971 |
RECENT ADVANCES AND TRENDS IN DRUG THERAPY. 3. HYPOTENSIVE AGENTS.
Topics: Antihypertensive Agents; Carbamates; Diazoxide; Drug Therapy; Guanethidine; Methyldopa; Pargyline; Toxicology | 1964 |